The impact of enzyme engineering upon natural product glycodiversification

Current Opinion in Chemical Biology

Volumn 12, Issue 5, 2008, Pages 556-564

  Williams, Gavin J ^a   Gantt, Richard W ^a   Thorson, Jon S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLTRANSFERASE; NATURAL PRODUCT;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME ENGINEERING; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STABILITY; ENZYME STRUCTURE; GLYCOSYLATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE METABOLISM; PROTEIN FOLDING; REVIEW; STEREOCHEMISTRY;

BIOLOGICAL PRODUCTS; DIRECTED MOLECULAR EVOLUTION; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; PROTEIN ENGINEERING; SUBSTRATE SPECIFICITY;

EID: 54049149694     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2008.07.013     Document Type: Review

References (71)

1. Williams GJ, Zhang C, Thorson JS: Natural product glycosyltransferases: Properties and applications. Adv Enzymol Relat Areas Mol Biol, 76, in press.
2. Weymouth-Wilson A.C. The role of carbohydrates in biologically active natural products. Nat Prod Rep 14 (1997) 99-110
3. Křen V., and Řezanka T. Sweet antibiotics - the role of glycosidic residues in antibiotic and antitumor activity and their randomization. FEMS Microbiol Rev 32 (2008) 858-889
4. Ahmed A., Peters N.R., Fitzgerald M.K., Watson Jr. J.A., Hoffmann F.M., and Thorson J.S. Colchicine glycorandomization influences cytotoxicity and mechanism of action. J Am Chem Soc 128 (2006) 14224-14225
5. Langenhan J.M., Peters N.R., Guzei I.A., Hoffmann F.M., and Thorson J.S. Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. Proc Natl Acad Sci U S A 102 (2005) 12305-12310
6. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J Nat Prod 70 (2007) 461-477
7. Newman D.J. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?. J Med Chem 51 (2008) 2589-2599
8. Butler M.S., and Newman D.J. Mother Nature's gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery. Prog Drug Res 65 1 (2008) 3-44
9. Butler M.S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Product Rep 25 (2008) 475-516
10. Shan M., and O'Doherty G.A. De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation. Org Lett 8 (2006) 5149-5152
11. Guo H., and O'Doherty G.A. De novo asymmetric synthesis of the anthrax tetrasaccharide by a palladium-catalyzed glycosylation reaction. Angew Chem Int Ed Engl 46 (2007) 5206-5208
12. Zhou M., and O'Doherty G.A. De novo approach to 2-deoxy-β-glycosides: asymmetric syntheses of digoxose and digitoxin. J Org Chem 72 (2007) 2485-2493
13. Langenhan J.M., Griffith B.R., and Thorson J.S. Neoglycorandomization and chemoenzymatic glycorandomization: two complementary tools for natural product diversification. J Nat Prod 68 (2005) 1696-1711
14. Griffith B.R., Krepel C., Fu X., Blanchard S., Ahmed A., Edmiston C.E., and Thorson J.S. Model for antibiotic optimization via neoglycosylation: Synthesis of liponeoglycopeptides active against VRE. J Am Chem Soc 129 (2007) 8150-8155. This paper describes the installation of all possible N-decanoylglucopyranose and N-biphenoylglucopyranose regioisomers onto the vancomycin aglycon. In contrast to prior work, optimal antibacterial activity via lipidation resulted from modification of the glucose C3' or C4'. This study highlighted the efficiency of neoglycorandomization in small molecule drug discovery.
15. Langenhan J.M., Engle J.M., Slevin L.K., Fay L.R., Lucker R.W., Smith K.R., and Endo M.M. Modifying the glycosidic linkage in digitoxin analogs provides selective cytotoxins. Bioorg Med Chem Lett 18 (2008) 670-673
16. Thibodeaux C.J., Melancon C.E., and Liu H.W. Unusual sugar biosynthesis and natural product glycodiversification. Nature 446 (2007) 1008-1016. This review expertly summarizes both in vivo and in vitro approaches to natural product glycodiversification.
17. Salas J.A., and Mendez C. Engineering the glycosylation of natural products in actinomycetes. Trends Microbiol 15 (2007) 219-232
18. Fu X., Albermann C., Zhang C., and Thorson J.S. Diversifying vancomycin via chemoenzymatic strategies. Org Lett 7 (2005) 1513-1515
19. Zhang C., Albermann C., Fu X., and Thorson J.S. The in vitro characterization of the iterative avermectin glycosyltransferase AveBI reveals reaction reversibility and sugar nucleotide flexibility. J Am Chem Soc 128 (2006) 16420-16421
20. Zhang C., Griffith B.R., Fu Q., Albermann C., Fu X., Lee I.K., Li L., and Thorson J.S. Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions. Science 313 (2006) 1291-1294. In this seminal report, the reversibility of four GTs was used to prepare more than 70 differentially glycosylated calicheamicin and vancomycin analogs in 'sugar-exchange' and 'aglycone-exchange' reactions.
21. Fu X., Albermann C., Jiang J., Liao J., Zhang C., and Thorson J.S. Antibiotic optimization via in vitro glycorandomization. Nat Biotechnol 21 (2003) 1467-1469
22. Minami A., Uchida R., Eguchi T., and Kakinuma K. Enzymatic approach to unnatural glycosides with diverse aglycon scaffolds using glycosyltransferase VinC. J Am Chem Soc 127 (2005) 6148-6149. This study reports on the substrate promiscuity of a macrolactam GT VinC. The authors discovered that the enzyme accepted both α- and β-anomers of several dTDP-2-deoxy-d-sugars to produce the β- and α-glycosides, respectively. Subsequently, a set of 22 diverse glycosides was constructed using VinC, and a mechanistic model proposed to explain the finding.
23. Minami A., and Eguchi T. Substrate flexibility of vicenisaminyltransferase VinC involved in the biosynthesis of vicenistatin. J Am Chem Soc 129 (2007) 5102-5107
24. Albermann C., Soriano A., Jiang J., Vollmer H., Biggins J.B., Barton W.A., Lesniak J., Nikolov D.B., and Thorson J.S. Substrate specificity of NovM: implications for novobiocin biosynthesis and glycorandomization. Org Lett 5 (2003) 933-936
25. Zhang C., Fu Q., Albermann C., Li L., and Thorson J.S. The in vitro characterization of the erythronolide mycarosyltransferase EryBV and its utility in macrolide diversification. ChemBioChem 8 (2007) 385-390
26. Hoffmeister D., Yang J., Liu L., and Thorson J.S. Creation of the first anomeric d/l-sugar kinase by means of directed evolution. Proc Natl Acad Sci U S A 100 (2003) 13184-13189
27. Yang J., Liu L., and Thorson J.S. Structure-based enhancement of the first anomeric glucokinase. ChemBioChem 5 (2004) 992-996
28. Yang J., Fu X., Liao J., Liu L., and Thorson J.S. Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomization. Chem Biol 12 (2005) 657-664
29. Barton W.A., Lesniak J., Biggins J.B., Jeffrey P.D., Jiang J., Rajashankar K.R., Thorson J.S., and Nikolov D.B. Structure, mechanism and engineering of a nucleotidylyltransferase as a first step toward glycorandomization. Nat Struct Biol 8 (2001) 545-551
30. Barton W.A., Biggins J.B., Jiang J., Thorson J.S., and Nikolov D.B. Expanding pyrimidine diphosphosugar libraries via structure-based nucleotidylyltransferase engineering. Proc Natl Acad Sci U S A 99 (2002) 13397-13402
31. Moretti R., and Thorson J.S. Enhancing the latent nucleotide triphosphate flexibility of the glucose-1-phosphate thymidylyltransferase RmlA. J Biol Chem 282 (2007) 16942-16947
32. Zhang C, Jiang J, Moretti R, Thorson J: The in vitro characterization of polyene glycosyltransferases AmphDI and NysDI. Chembiochem, in press.
33. Timmons S.C., Mosher R.H., Knowles S.A., and Jakeman D.L. Exploiting nucleotidylyltransferases to prepare sugar nucleotides. Org Lett 9 (2007) 857-860
34. Huestis M.P., Aish G.A., Hui J.P., Soo E.C., and Jakeman D.L. Lipophilic sugar nucleotide synthesis by structure-based design of nucleotidylyltransferase substrates. Org Biomol Chem 6 (2008) 477-484
35. Timmons S.C., Hui J.P., Pearson J.L., Peltier P., Daniellou R., Nugier-Chauvin C., Soo E.C., Syvitski R.T., Ferrieres V., and Jakeman D.L. Enzyme-catalyzed synthesis of furanosyl nucleotides. Org Lett 10 (2008) 161-163. Bacterial nucleotidyltransferases are usually used for the synthesis of hexopyranosyl nucleotides. This report describes the ability of several bacterial enzymes to couple four hexofuranosyl-1-phosphates with dTDP. This discovery should allow more extensive analysis of GT donor promiscuity.
36. Mizanur R.M., Zea C.J., Pohl N.L., Ko K.S., Zea C.J., and Pohl N.L. Unusually broad substrate tolerance of a heat-stable archaeal sugar nucleotidyltransferase for the synthesis of sugar nucleotides. J Am Chem Soc 126 (2004) 15993-15998
37. Ko K.S., Zea C.J., Pohl N.L., Mizanur R.M., Zea C.J., and Pohl N.L. Strategies for the chemoenzymatic synthesis of deoxysugar nucleotides: substrate binding versus catalysis. J Org Chem 70 (2005) 1919-1921
38. Moretti R., and Thorson J.S. A comparison of sugar indicators enables a universal high-throughput sugar-1-phosphate nucleotidyltransferase assay. Anal Biochem 377 (2008) 251-258
39. Khaled A., Piotrowska O., Dominiak K., and Auge C. Exploring specificity of glycosyltransferases: synthesis of new sugar nucleotide related molecules as putative donor substrates. Carbohydr Res 343 (2008) 167-178
40. Blanchard S., and Thorson J.S. Enzymatic tools for engineering natural product glycosylation. Curr Opin Chem Biol 10 (2006) 263-271
41. Rodriguez L., Aguirrezabalaga I., Allende N., Brana A.F., Mendez C., and Salas J.A. Engineering deoxysugar biosynthetic pathways from antibiotic-producing microorganisms. A tool to produce novel glycosylated bioactive compounds. Chem Biol 9 (2002) 721-729
42. Lombo F., Gibson M., Greenwell L., Brana A.F., Rohr J., Salas J.A., and Mendez C. Engineering biosynthetic pathways for deoxysugars: branched-chain sugar pathways and derivatives from the antitumor tetracenomycin. Chem Biol 11 (2004) 1709-1718
43. Perez M., Lombo F., Baig I., Brana A.F., Rohr J., Salas J.A., and Mendez C. Combinatorial biosynthesis of antitumor deoxysugar pathways in Streptomyces griseus: Reconstitution of "unnatural natural gene clusters" for the biosynthesis of four 2,6-D-dideoxyhexoses. Appl Environ Microbiol 72 (2006) 6644-6652
44. Lee H.Y., and Khosla C. Bioassay-Guided evolution of glycosylated macrolide antibiotics in Escherichia coli. PLoS Biology 5 (2007) 243-250. This article describes the construction and evolutionary-optimized macrolide glycosylation pathway in E. coli and sets the stage for high-level fermentation of novel macrolide glycosides.
45. Hui J.P., Yang J., Thorson J.S., and Soo E.C. Selective detection of sugar phosphates by capillary electrophoresis/mass spectrometry and its application to an engineered E. coli host. ChemBioChem 8 (2007) 1180-1188
46. Hoffmeister D., Ichinose K., and Bechthold A. Two sequence elements of glycosyltransferases involved in urdamycin biosynthesis are responsible for substrate specificity and enzymatic activity. Chem Biol 8 (2001) 557-567
47. Hoffmeister D., Wilkinson B., Foster G., Sidebottom P.J., Ichinose K., and Bechthold A. Engineered urdamycin glycosyltransferases are broadened and altered in substrate specificity. Chem Biol 9 (2002) 287-295
48. Kubo A., Arai Y., Nagashima S., and Yoshikawa T. Alteration of sugar donor specificities of plant glycosyltransferases by a single point mutation. Arch Biochem Biophys 429 (2004) 198-203
49. Kohara A., Nakajima C., Yoshida S., and Muranaka T. Characterization and engineering of glycosyltransferases responsible for steroid saponin biosynthesis in Solanaceous plants. Phytochemistry 68 (2007) 478-486
50. Mulichak A.M., Lu W., Losey H.C., Walsh C.T., and Garavito R.M. Crystal structure of vancosaminyltransferase GtfD from the vancomycin biosynthetic pathway: interactions with acceptor and nucleotide ligands. Biochemistry 43 (2004) 5170-5180
51. Bolam D.N., Roberts S., Proctor M.R., Turkenburg J.P., Dodson E.J., Martinez-Fleites C., Yang M., Davis B.G., Davies G.J., and Gilbert H.J. The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunity. Proc Natl Acad Sci U S A 104 (2007) 5336-5341. The Streptomyces antibioticus GTs OleI and OleD are involved in host cell immunity from endogenous and exogenous agents. The crystal structures of these enzymes in conjunction with active-site mutational analysis provided insight into the mechanism of action and substrate specificity. The failure however to engineer UDP-Glc/UDP-Gal activity or to alter acceptor macrolide specificity by loop grafting and mutagenesis highlights that directed evolution methods are likely required.
52. Martinez-Fleites C., Proctor M., Roberts S., Bolam D.N., Gilbert H.J., and Davies G.J. Insights into the synthesis of lipopolysaccharide and antibiotics through the structures of two retaining glycosyltransferases from family GT4. Chem Biol 13 (2006) 1143-1152
53. Hu Y., and Walker S. Remarkable structural similarities between diverse glycosyltransferases. Chem Biol 9 (2002) 1287-1296
54. Cartwright A.M., Lim E.K., Kleanthous C., and Bowles D.J. A kinetic analysis of regiospecific glucosylation by two glycosyltransferases of Arabidopsis thaliana: domain swapping to introduce new activities. J Biol Chem 283 (2008) 15724-15731
55. Brazier-Hicks M., Offen W.A., Gershater M.C., Revett T.J., Lim E.K., Bowles D.J., Davies G.J., and Edwards R. Characterization and engineering of the bifunctional N- and O-glucosyltransferase involved in xenobiotic metabolism in plants. Proc Natl Acad Sci U S A 104 (2007) 20238-20243. In vitro assay of a library of plant GTs identified a bifunctional N/O-GT. Subsequent crystal structure determination and successful protein engineering was used to provide unique insight into the dual N/O-glucosylation activity of the GT.
56. He X.Z., Wang X., and Dixon R.A. Mutational analysis of the Medicago glycosyltransferase UGT71G1 reveals residues that control regioselectivity for (iso)flavonoid glycosylation. J Biol Chem 281 (2006) 34441-34447
57. Ramakrishnan B., Boeggeman E., and Qasba P.K. Applications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI. Expert Opin Drug Deliv 5 (2008) 149-153
58. Qasba P.K., Boeggeman E., and Ramakrishnan B. Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol Prog 24 (2008) 520-526
59. Lairson L.L., Henrissat B., Davies G.J., and Withers S.G. Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem 77 (2008) 521-555
60. Offen W., Martinez-Fleites C., Yang M., Kiat-Lim E., Davis B.G., Tarling C.A., Ford C.M., Bowles D.J., and Davies G.J. Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification. EMBO J 25 (2006) 1396-1405
61. Mittler M., Bechthold A., and Schulz G.E. Structure and action of the C-C bond-forming glycosyltransferase UrdGT2 involved in the biosynthesis of the antibiotic urdamycin. J Mol Biol 372 (2007) 67-76
62. Zhang C., Bitto E., Goff R., Singh S., Bingman C., Griffith B., Albermann C., Phillips Jr. G., and Thorson J. Biochemical and structural insights of the early glycosylation steps in calicheamicin biosynthesis. Chem Biol 15 (2008) 842-853
63. 7 sialyltransferase mutants was rapidly selected and a variant obtained with a several-hundred fold increase in sialylation activity.
64. Williams G.J., Zhang C., and Thorson J.S. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution. Nat Chem Biol 3 (2007) 657-662. A simple fluorescence based screen employing a surrogate acceptor substrate was used to evolve for the first time a natural product GT. Promiscuity toward donor and acceptor was significantly broadened. This study provides a foundation for the creation of variant GTs with novel activities for use in drug discovery.
65. Yang M., Proctor M.R., Bolam D.N., Errey J.C., Field R.A., Gilbert H.J., and Davis B.G. Probing the breadth of macrolide glycosyltransferases: in vitro remodeling of a polyketide antibiotic creates active bacterial uptake and enhances potency. J Am Chem Soc 127 (2005) 9336-9337
66. Williams G.J., and Thorson J.S. A high-throughput fluorescence-based glycosyltransferase screen and its application in directed evolution. Nat. Protocols 3 (2008) 357-362
67. Burlison J.A., Avila C., Vielhauer G., Lubbers D.J., Holzbeierlein J., and Blagg B.S. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. J Org Chem 73 (2008) 2130-2137
68. Williams G.J., Goff R.D., Zhang C., and Thorson J.S. Optimizing glycosyltransferase specificity via "hot spot" saturation mutagenesis presents a catalyst for novobiocin glycorandomization. Chem Biol 15 (2008) 393-401
69. Carr R., Alexeeva M., Enright A., Eve T.S., Dawson M.J., and Turner N.J. Directed evolution of an amine oxidase possessing both broad substrate specificity and high enantioselectivity. Angew Chem Int Ed Engl 42 (2003) 4807-4810
70. Persson M., and Palcic M.M. A high-throughput pH indicator assay for screening glycosyltransferase saturation mutagenesis libraries. Anal Biochem 378 (2008) 1-7
71. Love K.R., Swoboda J.G., Noren C.J., and Walker S. Enabling glycosyltransferase evolution: a facile substrate-attachment strategy for phage-display enzyme evolution. Chembiochem 7 (2006) 753-756